Q: Hi, On September 24, insiders (CEO and others) sold over 400k shares @$11 of Sylogist. Jim Wilson, if I remember, also sold a large number of his personal holding alongside, the previous secondary offering @$8.90. President/CEO's personal stake in the co. being very important, any info on how much share holding Jim Wilson has now? Should this be a concern? Also, Acumen Financial managed both secondary offerings and have traded almost all the large block of shares recently, both on buy and sell, what could it mean? Mawer and CI already being the largest shareholders, any guess who would have been the buyers of these large blocks? Thanks for your valuable insight as always.
Q: On April 15 I asked you about significant insider selling. More took place (at $11) on the 24th just past. Is the selling timed to avoid any drop on the announcement of closing a financing and/or issue of new shares? Should we worry that the CEO's shareholding has dropped in stages from 2.4million back in February to 370thousand now?
Q: Re SYZ, On September 5th, the volume jumped to almost 600,000 on the sell side, almost 20 times the 100 day MA of about 31,000. There was a question/comment on this site talking about a new issue yet my source for news (Scotia iTrade) talks about a trading halt on the 4th with a resumption on the 5th. No other news. Can you fill in the blanks? Where, if I am not getting all the news from Scotia iTrade, can access ALL the news?
Q: Hi, Could you please provide your comments on Sylogist's just announced 2.5 mln shares secondary offering @11. Based on recent acquisitions and future acquisition potential, does the stock still offer decent upside? Thanks
Q: Syz is getting to be a big part of my portfolio,but it keeps going up on light trading,it looks like you lightened up on it in model port.at some time.Any advice?
Q: Peter and Team: I understand and agree with your decision to avoid target prices for stocks, but, having said that, I feel quite frustrated that I am unable to assess the risk-reward profile for a stock. I can only look at the chart and try to extrapolate.
Can you give me a sense of the risk-reward profile for two companies: Evertz Technologies (ET) and Sylogist (SYZ). Yahoo Finance shows 5-6 analysts covering Evertz. The low price target is $28 and the high target is $37. The stock is currently trading around $17. Are those realistic targets? Can you help me make sense of those targets (or provide one)? Yahoo shows no analyst coverage for SYZ. Can you give me a sense of its risk-reward, perhaps by comparing the two stocks? Thank you for continued great service.
Q: Peter: I have been looking at Sylogist, SYZ for the past few days as it reaches new highs. I'm puzzled by the reporting of volume. For example, today, the official count is 2615 but a look at trades on TMX.com shows many thousands more. Why the difference especially on what appears to be quite an illiquid stock, especially if you want to trade. Thank you and kind regards,
Q: Hi Peter and associates; SYZ has a good run this past while. My question is , do I add to my position at this price point or can you recommend one or two other growth stocks?
Thanks for your insight.
Q: Hi, Would appreciate your analysis of Sylogist Quarterly results. Stock has been trading as low as $8 while the financing was done @$8.90, not long ago.Will the dividend increase help the price recover, in your view? Thanks
I was wondering what percentage of Sylogist's (SYZ) revenue is relatively fixed or recurring in nature? I noticed they haven't announced any new contracts recently. Would the contracts they announced last year still largely be in effect this year?
Their 2013 Q4 numbers were a step change above that for 2012 with benefits being realized from the Epic Data aquisition. Do you expect this to continue and what would you expect in the way of EPS for Q1?